Borderline personality disorder | |
---|---|
Other names |
|
![]() | |
Idealization by Edvard Munch (1903), who is suggested to have had borderline personality disorder[6][7] | |
Specialty | Psychiatry, clinical psychology |
Symptoms | Unstable relationships, distorted sense of self, and intense emotions; impulsivity; recurrent suicidal and self-harming behavior; fear of abandonment; chronic feelings of emptiness; inappropriate anger; dissociation[8][9] |
Complications | Suicide, self-harm[8] |
Usual onset | Early adulthood[9] |
Duration | Long term[8] |
Causes | Genetic, neurobiologic, and psychosocial theories proposed |
Diagnostic method | Based on reported symptoms[8] |
Differential diagnosis | See § Differential diagnosis |
Treatment | Behaviour therapy[8] |
Prognosis | Improves over time,[9] remission occurs in 45% of patients over a wide range of follow-up periods[10][11][12][13][14] |
Frequency | 5.9% (lifetime prevalence)[8] |
Personality disorders |
---|
Cluster A (odd) |
Cluster B (dramatic) |
Cluster C (anxious) |
Other and unspecified |
Depressive |
Others |
Borderline personality disorder (BPD) is a personality disorder characterized by a pervasive, long-term pattern of significant interpersonal relationship instability, an acute fear of abandonment, and intense emotional outbursts.[9][15][16] People diagnosed with BPD frequently exhibit self-harming behaviours and engage in risky activities, primarily due to challenges regulating emotional states to a healthy, stable baseline.[17][18][19] Symptoms such as dissociation (a feeling of detachment from reality), a pervasive sense of emptiness, and distorted sense of self are prevalent among those affected.[15]
The onset of BPD symptoms can be triggered by events that others might perceive as normal,[15] with the disorder typically manifesting in early adulthood and persisting across diverse contexts.[9] BPD is often comorbid with substance use disorders,[20][21] depressive disorders, and eating disorders.[15] BPD is associated with a substantial risk of suicide;[9][15] studies estimated that up to 10 percent of people with BPD die by suicide.[22][23] Despite its severity, BPD faces significant stigmatization in both media portrayals and the psychiatric field, potentially leading to underdiagnosis and insufficient treatment.[24][25]
The causes of BPD are unclear and complex, implicating genetic, neurological, and psychosocial conditions in its development.[8][26] The current hypothesis suggests BPD to be caused by an interaction between genetic factors and adverse childhood experiences.[27][28] BPD is significantly more common in people with a family history of BPD, particularly immediate relatives, suggesting a possible genetic predisposition.[29] The American Diagnostic and Statistical Manual of Mental Disorders (DSM) classifies BPD in cluster B ("dramatic, emotional, or erratic" PDs) among personality disorders.[9] There is a risk of misdiagnosis, with BPD most commonly confused with a mood disorder, substance use disorder, or other mental health disorders.[9]
Therapeutic interventions for BPD predominantly involve psychotherapy, with dialectical behavior therapy (DBT) and schema therapy the most effective modalities.[8][25] Although pharmacotherapy cannot cure BPD, it may be employed to mitigate associated symptoms,[8] with atypical antipsychotics (e.g., Quetiapine) and selective serotonin reuptake inhibitor (SSRI) antidepressants commonly being prescribed, though their efficacy is unclear. A 2020 meta-analysis found the use of medications was still unsupported by evidence.[30]
BPD has a point prevalence of 1.6% and a lifetime prevalence of 5.9% of the global population,[9][8][31][32] with a higher incidence rate among women compared to men in the clinical setting of up to three times.[9][31] Despite the high utilization of healthcare resources by people with BPD,[33] up to half may show significant improvement over a ten-year period with appropriate treatment.[9] The name of the disorder, particularly the suitability of the term borderline, is a subject of ongoing debate. Initially, the term reflected historical ideas of borderline insanity and later described patients on the border between neurosis and psychosis. These interpretations are now regarded as outdated and clinically imprecise.[8][34]
Other signs or symptoms may include: [...] Impulsive and often dangerous behaviors [...] Self-harming behavior [...]. Borderline personality disorder is also associated with a significantly higher rate of self-harm and suicidal behavior than the general public.
People diagnosed with borderline personality disorder (BPD) are at high risk of dying by suicide: almost all report chronic suicidal ideation, 84% of patients with BPD engage in suicidal behavior, 70% attempt suicide, with a mean of 3.4 lifetime attempts per individual, and 5–10% die by suicide (Black et al., 2004; McGirr et al., 2007; Soloff et al., 1994).
The stigmatization of BPD is likely to be a result of several characteristics of the BPD syndrome. [... Pejorative] terms such as "difficult," "treatment resistant," "manipulative," "demanding," and "attention seeking" [are used to describe such individuals. This] can have an impact upon the treater's a priori expectations. [... Such] stigmatization is likely to be a result of several [behaviour characteristics of individuals with BPD, and the fact that] psychotherapy with [them] may involve disturbing and frightening behavior, including intense anger, chronic suicidal ideation, self-injury, and suicide attempts. [... Clinicians, under the stigma, may] see lower levels of [their patient's] functioning as deliberate and within [ones] control, or as manipulation, or as a rejection of help, [and may therefore respond] in unintentially damaging ways, [possibly by withdrawing] physically and emotionally. [...] It has been found that when one person has negative expectations of another, the former changes his or her behavior toward the latter. These interpersonal situations have been described as self-fulfilling prophecies.
[Clinicians] may hesitate to [provide treatment for BPD patients] due to discomfort working with the high-risk behaviours and intense interpersonal and emotional dysregulation typical of [the disorder. Treatments supported by empirical evidences include Dialectical behavior therapy, Mentalization-based treatment, Transference-focused psychotherapy, Schema-focused therapy, and General Psychiatric Magement... On the psychopathology side, it's possible that] emotional reactivity may be [more] pronounced [...] in response to social stressors and in interpersonal and self-conscious emotions (e.g., anger, shame) [...] Emotional vulnerability in BPD may also vary across specific emotions, [to which] sadness, hostility, and fear [are particularly damaging].
In addition to the evidence identified by the systematic review, the Committee also considered a recent narrative review of studies that have evaluated biological and environmental factors as potential risk factors for BPD (including prospective studies of children and adolescents, and studies of young people with BPD)
The current hypothesis is that BPD is caused by an interaction between genetic factors and adverse childhood experiences affecting brain development via neuropeptides and hormones. The relative importance of these factors is unclear.
The causes are not yet clear, but genetic factors and adverse life events seem to interact to lead to the disorder. Neurobiological research suggests that abnormalities in the frontolimbic networks are associated with many of the symptoms. Data for the effectiveness of pharmacotherapy vary and evidence is not yet robust. Specific forms of psychotherapy seem to be beneficial for at least some of the problems frequently reported in [BPD] patients [... As of 2011,] there is no evidence to suggest that one specific form of psychotherapy is more effective than another.
[We] performed a systematic review of the literature concerning the genetics of BPD, including familial and twin studies, association studies, and gene–environment interaction studies. [...] Familial and twin studies largely support the potential role of a genetic vulnerability at the root of BPD, with an estimated heritability of approximately 40%. [There] is evidence for both gene–environment interactions and correlations. However, association studies for BPD are sparse, making it difficult to draw clear conclusions.
stofferswinterling20
was invoked but never defined (see the help page).
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search